Menu

Japanese Authorities Recommend Not Regulating Gene Editing

Unlike judges in the European Union, a government panel in Japan says transgenic modification and genome editing are not the same.

Aug 22, 2018
Kerry Grens

ABOVE: © ISTOCK, VISUALSPACE

A Japanese government panel announced Monday (August 20) that it recommends regulating only genetically modified organisms that have had foreign genes permanently introduced into their genomes and not those whose endogenous genes have been edited, according to NHK World-Japan. This means that developers will not have to get approval from the government to produce gene-edited organisms, The Mainichi reports.

The only stipulation is that researchers and businesses will have to register their modifications to plants or animals with the government, with the exception of microbes cultured in contained environments. “We judged that there needed to be some kind of management system in place to earn consumers’ trust,” a panel member tells The Mainichi.

See “The Unregulation of Biotech Crops

Reactions to the decision are mixed. A representative from the Japan Bioindustry Association expressed support to NHK for the recommendation. While lauding the potential benefits of genome editing, an editorial in The Asahi Shimbun opposes across-the-board permission. “Since it is a new technique, there is no ruling out unforeseen risks in gene editing,” it reads. “There have actually been reports on unintended mutations as a result of gene editing.”

The newspaper recommends following the lead of the European Court of Justice, which last month decided that genetically modified products must go through the same safety and labeling processes regardless of method.

See “No Regulatory Exemption for Gene-Edited Products in EU

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.